SCHEMBL6038379

SCHEMBL6038379

CC(C)(C)OC(=O)NCCCCNS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
TSHR P16473 1/20 0.58
HDAC1 Q13547 1/20 0.57
HDAC2 Q92769 1/20 0.57
CA1 P00915 9/20 0.53
CA2 P00918 9/20 0.53
CA12 O43570 7/20 0.53
CA9 Q16790 7/20 0.53
MMP2 P08253 5/20 0.51
MMP9 P14780 2/20 0.51
NPSR1 Q6W5P4 1/20 0.50
MMP1 P03956 1/20 0.50
GAA P10253 1/20 0.50
MMP12 P39900 1/20 0.50
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
PKM P14618 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
BRD4 O60885 1/20 0.48
TBXA2R P21731 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27202571 0.93 MMP2 (0.53) ALDH1A1TSHRHDAC1HDAC2CA1
SCHEMBL569559 0.88 CA1 (0.65) ALDH1A1TSHRCA1CA2CA12
SCHEMBL569562 0.87 CA12 (0.65) ALDH1A1TSHRCA1CA2CA12
SCHEMBL569947 0.87 CA12 (0.65) ALDH1A1TSHRCA1CA2CA12
SCHEMBL5094941 0.85 ALDH1A1 (0.60) ALDH1A1TSHRCA1CA2CA12
SCHEMBL14831226 0.84 USP2 (0.56) ALDH1A1TSHRCA1CA2CA12
SCHEMBL24762017 0.84 ALDH1A1 (0.60) ALDH1A1TSHRCA1CA2CA12
SCHEMBL29764347 0.84 CA1 (0.56) ALDH1A1TSHRCA1CA2CA12
SCHEMBL29262772 0.83 CA12 (0.59) ALDH1A1TSHRCA1CA2CA12
Dimethylamine SCHEMBL7701793 0.83 ALDH1A1 (0.48) ALDH1A1TSHRHDAC1HDAC2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 ALDH1A1 781/4885TSHR 2191/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.